February 27, 2026 · Form 4 insider transaction
Krishnan Krish S bought 22,500 shares of Krystal Biotech, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
45,000 performance stock units ("PSUs") were granted on February 29, 2024, to the Reporting Person's spouse, Suma M. Krishnan. Each PSU represented a contingent right to receive one share of the Company's common stock, subject to the achievement of certain performance criteria during the year ended December 31, 2024, as approved by the Company's Compensation Committee, and the Reporting Person's spouse continued service to the Company on each applicable vesting date following such achievement. The PSUs vested ratably over a two-year period. All of the performance criteria were achieved and the remaining one-half of the PSUs granted, or 22,500 PSUs, vested on February 27, 2026.; These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Suma M. Krishnan.; Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person.